SCHEMBL25596704

SCHEMBL25596704

CC(=O)C(C)(C)Cc1ccc(O)c(O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.60
HSD17B10 Q99714 7/20 0.60
ALOX15 P16050 7/20 0.60
HPGD P15428 6/20 0.60
MAPT P10636 5/20 0.60
TDP1 Q9NUW8 5/20 0.60
ALDH1A1 P00352 5/20 0.60
POLB P06746 4/20 0.60
CYP3A4 P08684 4/20 0.60
BLM P54132 4/20 0.60
RECQL P46063 4/20 0.60
CYP1A2 P05177 3/20 0.60
PMP22 Q01453 3/20 0.60
USP2 O75604 3/20 0.60
PTGS2 P35354 3/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
GAA P10253 2/20 0.60
APEX1 P27695 2/20 0.60
EGFR P00533 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13644181 0.85 KDM4E (0.70) KDM4EHSD17B10ALOX15HPGDMAPT
SCHEMBL25846202 0.82 KDM4E (0.76) KDM4EHSD17B10ALOX15HPGDMAPT
SCHEMBL13431276 0.82 KDM4E (0.76) KDM4EHSD17B10ALOX15HPGDMAPT
SCHEMBL19368947 0.80 HSD17B10 (0.61) KDM4EHSD17B10ALOX15HPGDMAPT
SCHEMBL15920346 0.78 HSD17B10 (0.78) KDM4EHSD17B10ALOX15HPGDMAPT
SCHEMBL2600039 0.78 ALOX15 (0.59) KDM4EHSD17B10ALOX15HPGDMAPT
Methyldopa (Racemic) SCHEMBL28969518 0.76 KDM4E (0.94) KDM4EHSD17B10ALOX15HPGDMAPT
SCHEMBL23754771 0.75 KDM4E (0.76) KDM4EHSD17B10ALOX15HPGDMAPT
Methyldopa SCHEMBL34003 0.75 KDM4E (1.00) KDM4EHSD17B10ALOX15HPGDMAPT
SCHEMBL23754770 0.75 KDM4E (0.76) KDM4EHSD17B10ALOX15HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666539-B2 Synthetic lipid-like materials for brain delivery TRUSTEES OF TUFTS COLLEGE (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11666539-B2 Synthetic lipid-like materials for brain delivery NPC1L1, FABP7, LIPA KDM4E 3759/4885HSD17B10 510/4885ALOX15 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.